S
Sirnaomics
Gaithersburg, United States
Founded 2007 NASDAQ: SIRN
About
Clinical-stage biopharmaceutical company developing RNAi therapeutics using polypeptide nanoparticle delivery
Company Details
- Type
- commercial
- Employees
- 100-200
- Funding
- Public
Key Products
- STP705
- GalNAc-RNAi Platform